Anocca is a fully integrated biopharmaceutical company that develops libraries of T-cell receptor-engineered T cell (TCR-T) therapies to redefine the treatment of solid tumours and other difficult to treat diseases, including infectious and autoimmune diseases. Its unique discovery engine uses programmable human cells to recreate and manipulate T cell immunity. This proprietary technology scales TCR-T cell therapy development, allowing the systematic generation of personalised treatments for the broadest patient populations.
Anocca operates an advanced research and development infrastructure, underpinned by a custom software ecosystem, AnoccaOS, and in-house cGMP manufacturing and process development facilities. All Anocca’s therapeutic TCRs are novel discoveries from its platform and manufactured using non-viral gene editing technology at Anocca’s facilities in Sweden.
Company Details
- Employees
- 120
- Founded
- -
- Address
- Forskargatan 20c, B229,sweden
- Phone
- 46841080757
- in****@****cca.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- anocca.com
- Keywords
- Biotechnology, Immunotherapeutics, Drug Discovery, Drug Development, Immunology, Immunotechnology, Immuno-Oncology.
- HQ
- Södertälje
Anocca Questions
Anocca's helpline number is 46841080757
Anocca's website is anocca.com
Anocca's LinkedIn profile is https://se.linkedin.com/company/anocca-ab
Anocca has
120 employees.
View email and phone details for 120
employees at Anocca.
Anocca's industry is
Biotechnology Research
Anocca's top competitors are
Pelago Bioscience Ab,
Northx Biologics,
Bioarctic,
Cellcolabs,
Atmp Sweden,
Smartcella Holding Ab,
Nextcell Pharma Ab,
Atlas Antibodies,
Affibody Ab,
Biolamina.
Anocca's support email address is info@anocca.com
Anocca's categories are Biotechnology Research
Anocca's founding year is 2014
